Benitec Biopharma Ltd (BNTC): Fierce biotech on Benitec http://www.fie...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Benitec Biopharma Ltd (BNTC)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	42
Posts	2198
Boards Moderated	0
Alias Born	02/10/2014

Re: None

Tuesday, 08/25/2015 11:48:23 AM

Tuesday, August 25, 2015 11:48:23 AM

Fierce biotech on Benitec http://www.fiercedrugdelivery.com/story/benitec-ipo-swoons-amid-market-rout-other-drug-delivery-focused-players-sti/2015-08-24

"The company touts its approach to RNA interference, known as DNA-directed RNAi, saying it's better than the approach to gene silencing used by Alnylam ($ALNY), Arrowhead Research ($ARWR) and others."

"Apparently, advantages of this approach include reduced toxicity and side effects because ddRNAi requires a small dosage of the DNA construct to achieve genetic change, Benitec says on its website. Late-stage trials of the hepatitis C med are expected to commence in Q2 2017. In addition, Calimmune has a license to use Benitec's ddRNAi platform on its Phase I/II candidate for HIV/AIDs."

All my posts, comments, and investments are not to be considered investment advice in any way.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BNTC News

Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:17:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:13:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:12:19 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/06/2024 05:15:18 AM
Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 02/26/2024 02:06:56 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/23/2024 09:09:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 01:01:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:15:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 12:31:00 PM
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/17/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:03:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:49 PM
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/20/2023 08:31:26 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2023 10:04:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 09:19:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 12:05:29 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/21/2023 12:00:53 PM
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 09:26:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:01:00 PM
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/11/2023 05:00:12 PM

More BNTC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow